Bionano Genomics, Inc.
BNGO
$1.85
$0.042.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.37M | 6.73M | 6.46M | 8.16M | 6.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.37M | 6.73M | 6.46M | 8.16M | 6.07M |
| Cost of Revenue | 4.00M | 3.26M | 3.52M | 4.75M | 14.52M |
| Gross Profit | 3.37M | 3.48M | 2.94M | 3.42M | -8.45M |
| SG&A Expenses | 9.06M | 8.35M | 9.03M | 856.00K | 9.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.91M | 14.53M | 14.92M | 9.08M | 28.70M |
| Operating Income | -8.54M | -7.80M | -8.47M | -913.00K | -22.63M |
| Income Before Tax | -8.49M | -6.85M | -3.10M | -20.12M | -44.22M |
| Income Tax Expenses | 14.00K | 10.00K | 7.00K | 1.00K | 24.00K |
| Earnings from Continuing Operations | -8.50M | -6.86M | -3.10M | -20.13M | -44.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.50M | -6.86M | -3.10M | -20.13M | -44.25M |
| EBIT | -8.54M | -7.80M | -8.47M | -913.00K | -22.63M |
| EBITDA | -6.11M | -5.37M | -5.98M | 1.33M | -16.95M |
| EPS Basic | -1.59 | -1.99 | -1.15 | -12.22 | -30.92 |
| Normalized Basic EPS | -0.99 | -1.24 | -0.72 | -0.67 | -10.02 |
| EPS Diluted | -1.59 | -1.99 | -1.15 | -12.22 | -30.92 |
| Normalized Diluted EPS | -0.99 | -1.24 | -0.72 | -0.67 | -10.02 |
| Average Basic Shares Outstanding | 5.34M | 3.44M | 2.69M | 1.65M | 1.43M |
| Average Diluted Shares Outstanding | 5.34M | 3.44M | 2.69M | 1.65M | 1.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |